Medpace Holdings (MEDP) Other Non-Current Liabilities (2015 - 2026)

Medpace Holdings has reported Other Non-Current Liabilities for 12 years, with the latest figure at $60.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 13.51% year-over-year to $60.1 million; the trailing twelve-month figure through Mar 2026 stood at $60.1 million (up 13.51% YoY), and the FY2025 full-year result was $57.7 million, up 34.92% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $60.1 million, up from $57.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $60.1 million in Q1 2026, with the low at $17.2 million in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $34.2 million across 5 years, with a median of $29.1 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities increased 6.93% — and 2025, when it soared 82.07%.
• Medpace Holdings' Other Non-Current Liabilities stood at $22.7 million in 2022, then gained by 24.32% to $28.2 million in 2023, then jumped by 51.43% to $42.7 million in 2024, then soared by 34.92% to $57.7 million in 2025, then rose by 4.25% to $60.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $60.1 million (Q1 2026), $57.7 million (Q4 2025), and $54.5 million (Q3 2025), per Business Quant data.